Affiliation:
1. SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, ANKARA DR. ABDURRAHMAN YURTASLAN ONKOLOJİ SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ
Abstract
Objective: Atherogenic index of plasma is a relatively new index used to predict the risk of cardiovascular diseases in the general population. Our aim was to investigate association between the development of retinal vein occlusion and atherogenic index of plasma.
Material and Method: A total of 24 patients with retinal vein occlusion and 24 age-sex matched healthy individuals were included in this retrospective study. The demographic characteristics and laboratory findings of the patients and control subjects were obtained from the electronic medical records. Atherogenic index of plasma was calculated as the logarithmical ratio of molar concentrations of triglycerides to high density lipoprotein cholesterol as. The association among atherogenic index of plasma, lipid metabolism parameters, and retinal vein occlusion was analyzed.
Results: The median age was 69.5 (range, 48-86) in the patient group and 71.5 (range, 50-84) in the control group (p=812). Although there were no significant differences in terms of total cholesterol and low-density lipoprotein cholesterol between two groups (P=0.458, 0.88), atherogenic index of plasma was significantly higher in the patient group (P
Reference29 articles.
1. 1. Cugati S, Varma DD, Chen CS, Lee AW. Treatment Options for Central Retinal Artery Occlusion. Curr. Treat. Options Neurol 2012;15:63–77.
2. 2. Terao R, Fujino R, Ahmed T. Risk Factors and Treatment Strategy for Retinal Vascular Occlusive Diseases. J Clin Med 2022;11: 6340.
3. 3. Klein R, Klein EB, Moss ES, Meuer SM. The epidemiology of retinal vein occlusion: The Beaver Dam Eye Study. Trans Am OphthalmolSoc 2000;98:133–143.
4. 4. Song P, Xu Y, Zha M, Zhang Y, Rudan I. Global epidemiology of retinal vein occlusion: A systematic review and meta-analysis of prevalence, incidence, and risk factors. J Glob Health 2019;9:010427.
5. 5. Di Capua M, Coppola A, Albisinni R, et al. Cardiovascular risk factors and outcome in patients with retinal vein occlusion. J Thromb Thrombolysis 2009;30:16–22.